Balaraman Kalyanaraman

This inventor holds 16 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: The Medical College of Wisconsin, Inc., Aix-Marseille Université, Mcw Research Foundation, Inc.. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Balaraman Kalyanaraman. Retrieved from https://idiyas.com/inventor/balaraman-kalyanaraman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 7)

% Patents Active = 75.0

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 8(Granted Patents)

Location History:

Wauwatosa, WI (US) (2007 - 2022)
Milwaukee, WI (US) (2003 - 2024)

Company Filing History:

12 out of 194

The Medical College of Wisconsin, Inc.

patents

6 out of 13

Aix-Marseille Université

patents

3 out of 61

Mcw Research Foundation, Inc.

patents

4. 2 out of 1,426

Iowa State University Research Foundation Inc.

patents

5. 1 out of 3

Colby Pharmaceutical Company

patents

6. 1 out of 15

Lodz University of Technology

patents

7. 1 out of 8

Université De Provence

patents

8. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2026

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12594283 - Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug (2026-04-07),

2. 12358935 - Targeting redox-active pyridinium cations to mitochondria to inhibit proliferation of drug-resistant cancer cells (2025-07-15),

3. 11897910 - Mito-honokiol compounds and methods of synthesis and use thereof (2024-02-13),

4. 11612610 - Mito-magnolol compounds and methods of synthesis and use thereof (2023-03-28),

5. 11352382 - Mito-lonidamine, compositions and methods of use (2022-06-07),

6. 11083739 - Mito-magnolol compounds and methods of synthesis and use thereof (2021-08-10),

7. 10836782 - Mito-honokiol compounds and methods of synthesis and use thereof (2020-11-17),

8. 10576093 - Neuroprotection by mitochondria-targeted metformin (2020-03-03),

9. 9956233 - Neuroprotection by mitochondria-targeted metformin (2018-05-01),

10. 8962600 - Neuroprotective compounds and their use (2015-02-24),

11. 8466130 - Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers (2013-06-18),

12. 8388936 - In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging (2013-03-05),

13. 8388931 - 99m Tc-labeled triphenylphosphonium derivative contrasting agents and molecular probes for early detection and imaging of breast tumors (2013-03-05),

14. 8143420 - Bifunctional and trifunctional nitrone spin trapping compounds and uses thereof (2012-03-27),

15. 7223864 - 2-hydroxyethidium, methods of preparation and uses thereof (2007-05-29),

Title: The Innovative Journey of Balaraman Kalyanaraman

Introduction:

Balaraman Kalyanaraman, a distinguished inventor hailing from Wauwatosa, WI (US), has made significant contributions to the field of innovation through his groundbreaking work in various patents.

Latest Patents:

Balaraman Kalyanaraman's recent patents showcase his commitment to pushing the boundaries of technology and science, with a focus on improving healthcare solutions and environmental sustainability.

Career Highlights:

Throughout his illustrious career, Balaraman Kalyanaraman has garnered recognition for his pioneering research in areas such as biotechnology, renewable energy, and information technology. His innovative spirit has led to the development of cutting-edge products that have revolutionized their respective industries.

Collaborations:

Balaraman Kalyanaraman has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work across disciplines and sectors has resulted in the successful implementation of numerous patented technologies.

Conclusion:

In conclusion, Balaraman Kalyanaraman stands as a testament to the power of innovation and perseverance in driving positive change. His contributions to the world of inventions continue to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.